Mumbai, July 24 -- Zydus Lifesciences has received tentative approval from the United States Food and Drug Administration (USFDA) for Ibrutinib tablets 140 mg, 280 mg, and 420 mg (USRLD: Imbruvica(R) tablets, 140 mg, 280 mg and 420 mg).

Published by HT Digital Content Services with permission from Capital Market....